Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice

AIDS

Volumn 11, Issue 6, 1997, Pages 727-736

  Rusnati, Marco ^a   Coltrini, Daniela ^a   Campioni, Diana ^b   Tanghetti, Elena ^a   Corallini, Alfredo ^b   Barbanti Brodano, Giuseppe ^b   Giuliani, Roberta ^a   Gibellini, Davide ^c   Presta, Marco ^a,d  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Dept of Biomed Sci and Biotech ^*  (Italy)

Author keywords

HIV 1 Tat; Plasminogen activators; Proteolysis

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CHLOROQUINE; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; HEPARIN; HYBRID PROTEIN; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSACTIVATOR PROTEIN; UROKINASE;

ADENOCARCINOMA; ANIMAL CELL; ARTICLE; BK VIRUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FIBRINOLYSIS; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; LEIOMYOSARCOMA; LONG TERMINAL REPEAT; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; TRANSACTIVATION; TRANSGENE; TUMOR CELL LINE;

EID: 0031002107     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199706000-00005     Document Type: Article

References (74)

1. Barrè-Sinoussi F, Chermann JC, Rey F, et al.: Isolation of a T-lymphotrophic retrovirus from a patient at risk for acquired immunodeficiency syndrome. Science 1983, 220:868 871.
2. Gallo RC, Salahuddin M, Popovic M, et al.: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224:500 503.
3. Schwartz S, Felber BK, Benko DM, et al.: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus. J Virol 1990, 64:2519 2529.
4. Cullen BR: The HIV-1 Tal protein: an RNA sequence-specific processivity factor? Cell 1990, 63:655 657.
5. Sodroski JG, Patarca R, Rosen C, et al.: Location of the trans-acting region of the genome of human T-cell lymphotrophic virus type III. Science 1985, 229:74 77.
6. Arya SK, Guo C, Josephs SE, Wong Staaf F: Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 1985, 229:69 73.
7. Sodroski JG, Rosen CA, Wong-Staal F, et al.: Trans-acting transcriptional regulation of human T-cell leukemia virus type III (HTLV-III) long terminal repeat. Science 1985, 227:171-173.
8. Rosen CA, Sodroski JG, Haseltine WA: The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 1985, 41:813-823.
9. Jakobovils A, Smith DH, Jakobovits EB, Capon DJ: A discrete element 3′ of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans-activator. Mol Cell Biol 1988, 8:2555 2561.
10. Peterlin BM, Adams M, Alonso A, et al.: Tat trans-activator. In Human Retroviruses. Edited by Cullen BR. Oxford: Oxford University Press; 1993:75 100.
11. Erankel AD, Pabo CO: Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 1988, 55:1189 1193.
12. Kolson DL, Collman R, Hrin R, et al.: Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation. J Gen Virol 1994, 75:1927-1934.
13. Nabell LM, Raja H, Sayeski P, et al.: Human immunodeficiency virus 1 Tat stimulates transcription of the transforming growth factor alpha gene in an epidermal growth factor-dependent manner. Cell Growth Differ 1914, 5:87 93.
14. Zauli G, Davis BR, Re MC, et al.: Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 1992, 80:3035 3043.
15. Lotz M, Clark-Lewis J, Ganu V: HIV-1 transactivator Tat induces proliferation and TGFβ expression in human articula chondrocytes. J Cell Biol 1994, 124:365 371.
16. Opalenik SR, Shin JL, Wehby JN, et al.: The HIV-1 Tat protein induces the expression and extracellular appearance of acidic fibroblast growth factor. J Biol Chem 1995, 270:17457 17467.
17. Philippon V, Vellutini C, Gamabarelli D, et al.: The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 1994, 205:519 528.
18. Purvis SE, Georges DL, Williams TM, Lederman MM: Suppression of interleukin-2 and interleukin-2 receptor expression in jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell Immunol 1992, 144:32-42.
19. Westendorp MO, Li-Weber M, Erank RW, Krammer PH: Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 1994, 68:4177 4185.
20. Vacca A, Farina M, Maroder M, et al.: Human immunodeficiency virus Type-1 Tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motifs. Biochem Biophys Res Commun 1994, 205:467 474.
21. Zauli G, Furlini G, Re MC, et al.: Human immunodeficiency virus type 1 (HIV-1) Tat-protein stimulates the production of interleukin-6 (IL-6) by peripheral blood monocytes. Microbiologica 1993, 16:115 120.
22. Scala G, Ruocco MR, Ambrosino C, et al.: The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med 1994, 179:961-971.
23. Pocsik F, Higuchi M, Aggrawal BB: Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. Lymphokine Cytokine Res 1992, 11:317-325.
24. Milani D, Zauli G, Neri EM, et al.: Influence of the human immunodeficiency virus type 1 Tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J Gen Virol 1993, 74:2587 2594.
25. Puri RK, Aggarwal BB: Human immunodeficiency virus type-1 tat gene upregulates interleukin-4 receptors on a human B-lymphoblastoid cell line. Cencer Res 1992, 52:3787 3790.
26. Albini A, Barillari G, Benelli R, et al.: Angiogenic properties of human immunodeficiency virus type-1 Tat protein. Proc Natl Acad Sci USA 1995, 92:4838 4842.
27. Albini A, Fontanini G, Masiello L, et al.: Angiogenic potential in vivo by Kaposi sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesion by tissue inhibitor of metalloproteinase-2. AIDS 1994, 8:1237-1244.
28. Albini A, Benelli R, Presta M, et al.: HIV-1 Tat protein is a heparin-binding angiogenic growth factor. Oncogene 1996, 12:289 297.
29. Corallini A, Campioni D, Rossi C, et al.: Promotion of tumor metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/Tat transgenic mice. AIDS 1996, 10:701-710.
30. Ensoli B, Barillari G, Salahuddin SZ, et al.: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990, 345:84 86.
31. Barillari G, Bonaguro L, Fiorelli V, et al.: Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 1992, 149:3727-3734.
32. Hofman FM, Wright DW, Dohadwala MM, et al.: Exogenous Tat protein activates human endothelial cells. Blood 1993, 82:2774-2780.
33. Hofman FM, Dohadwala MM, Albion DW, et al.: Exogenous Tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 1994, 54:19 28.
34. 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 1993, 121:461-468.
35. Barillari G, Gendelman R, Gallo RC, Ensoli B: The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 1993, 90:7941-7945.
36. Campioni D, Corallini A, Zauli G, et al.: HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res Hum Retrovirus 1995, 11:1039-1048.
37. Albini A, Soldi R, Giunciuglio D, et al.: The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nature Med 1996, 2:1371-1375.
38. Ensoli B, Gendelman R, Markham P, et al.: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994, 271:674 680.
39. Vogel I, Hinrichs SH, Reynolds RK, et al.: The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988, 335:606 611.
40. Corallini A, Altavilla G, Pozzi L, et al.: Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 1993, 53:5569 5575.
41. Kim CM, Vogel J, Jay GR, Rhim JS: The HIV tat gene transforms human keratinocytes. Oncogene 1992, 7:1525 1529.
42. Mak IW, Rutledge G, Sutherland DJA: Androgen-dependent fibrinolytic activity in murine mammary carcinoma (Shionogi SC-115) cells in vitro. Cell 1976, 7:223 226.
43. Butler WB, Kirkland WL, Jorgensen T: Induction of plasminogen activator by estrogen in human breast cancer cell line (MCF-7). Biochem Biophys Res Commun 1979, 90:1328 1334.
44. Noguchi-Takino M, Endo Y, Yonemura Y, Sasaky L: Relationship between expression of plasminogen activator system and metastatic ability in human cancers. Int J Oncol 1996, 8:97 105.
45. Saksela O, Rifkin DB: Cell-associated plasminogen activation: regulation and physiological functions. Ann Rev Cell Biol 1988, 4:93 126.
46. Ossowsky L: Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase. Cencer Res 1992, 52:6754-6760.
47. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73:161 195.
48. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/plasmin system. J Clin Invest 1991, 88:1067 1072.
49. Pepper MS, Montesano R: Proteolytic balance and capillary morphogenesis. Cell Differ Dev 1990, 32:319 328.
50. Isacchi A, Statuto M, Chiesa R, et al.: A six amino acid deletion in basic fibroblast growth factor dissociated its mitogenic activity from its plasminogen activator-inducing capacity. Proc Natl Acad Sci USA 1991, 88:2628-2632.
51. Wright CM, Selber BK, Paskalis H, Pavlakis GN: Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science 1986, 234:988 992.
52. Caputo A, Sodroski JG, Haseltine WA: Constitutive expression of HIV-1 Tat protein in human jurkat T cells using a BK virus vector. J Acquir Immune Defic Syndr 1990, 3:372 379.
53. Graham EL, Van der Lb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52:456-467.
54. Wigler M, Pellicer A, Silverstein S, et al.: DNA mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci USA 1979, 76:1373-1376.
55. Colombi M, Rebessi L, Boiocchi M, et al.: Relationship between circulating plasminogen activators and tumor development in mice. Cancer Res 1986, 46:5748-5753.
56. Coffey RJ, Leof FB, Shipley GD, Moses HL: Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 1987, 132:143-148.
57. Rusnati M, Dell'Era P, Urbinati C, et al.: A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells. Mol Cell Biol 1996, 7:369 381.
58. Moscatelli D, Quarto N: Transformation of NIH3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes down-regulation of the fibroblast growth factor receptor: reversal of morphologic transformation and restoration of receptor number by suramin. J Cell Biol 1989, 109:2519-2527.
59. Huang SS, Huang JS: Rapid turnover of the platelet-derived growth factor receptor in cis-transformed cells and reversal by suramin. J Cell Biol 1988, 263:12608 12618.
60. Kasayama S, Saito H, Kouhara H, et al.: Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (shionogi carcinoma 115) cells. J Cell Physiol 1993, 154:254 261.
61. Presta M, Moscatelli D, Joseph-Silverstein J, Rifkin DB: Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol 1986, 6:4060-4066.
62. Laiho M, Keski-Oja J: Growth factor in the regulation of pericellular proteolysis: a review. Cancer Res 1989, 54:2533-2553.
63. Vassalli JD, Belin D: Amiloride selectively inhibits urokinase-type plasminogen activator. FEBS Lett 1987, 214:187-191.
64. Andreasen PA, Nielsen LS, Kristensen P, et al.: Plasminogen activator inhibitor from human fibrosacroma cells binds urokinase-type plasminogen activator, but not its proenzyme. J Biol Chem 1986, 261:7644-7651.
65. Franco PM, Mastronicola R, De Cesare D, et al.: Separation and characterization of nonphosphorylated and serine-phosphorylated urokinase. J Biol Chem 1992, 267:19369-19372.
66. Caputo A, Grossi M, Rossi C, et al.: The tat gene and protein of the human immunodeficiency virus type 1. Microbiologica 1995, 18:87 110.
67. Mann DA, Frankel AD: Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 1991, 10:1733-1739.
68. Rusnati M, Coltrini D, Oreste P, et al.: Interaction of HIV-1 Tat protein with heparin. J Biol Chem 1997 (in press).
69. Ensoli B, Buonaguro L, Barillari G, et al.: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transcription. J Virol 1993, 67:277-287.
70. Rusnati M, Presta M: Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Int J Clin Lab Res 1996, 26:15-23.
71. Besser D, Presta M, Nagamine Y: Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblast. Cell Growth Differ 1995, 6:1009-1017.
72. Plopper GE, McNamee HP, Dike LE, et al.: Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Cell Biol 1995, 6:1349-1365.
73. Schwartz MA, Schaller MD, Ginsberg MH: Integrins: emerging paradigms of signal transduction. Annu Rev Cell Biol 1995, 11:549-599.
74. Goldstein G: HIV-1 Tat protein as a potential AIDS vaccine. Nature Med 1996, 1:960 964.